PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA
Duoduo Zhao(First Affiliated Hospital Zhejiang University), Carsten Müller‐Tidow(Heidelberg University), Stefanie Huhn(Heidelberg University), Michaela Frye(German Cancer Research Center), Anna Luise Grab(German Cancer Research Center), Niels Weinhold(German Cancer Research Center), Christian Rohde(Heidelberg University), Marc‐Steffen Raab(Heidelberg University), M. Kienhöfer(Heidelberg University), Cornelius Pauli(German Cancer Research Center)
Cited by 1
Related Papers
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
|Nature Communications|2017|418
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
|Molecular Cell|2009|315
RNA modifications in physiology and disease: towards clinical applications
|Nature Reviews Genetics|2023|294